ZA89441B - Aromatic esters and thioesters,a process for their preparation and their use in human or veterinary medicine and in cosmetic compositions - Google Patents

Aromatic esters and thioesters,a process for their preparation and their use in human or veterinary medicine and in cosmetic compositions

Info

Publication number
ZA89441B
ZA89441B ZA89441A ZA89441A ZA89441B ZA 89441 B ZA89441 B ZA 89441B ZA 89441 A ZA89441 A ZA 89441A ZA 89441 A ZA89441 A ZA 89441A ZA 89441 B ZA89441 B ZA 89441B
Authority
ZA
South Africa
Prior art keywords
thioesters
lower alkyl
aromatic esters
human
hydrogen
Prior art date
Application number
ZA89441A
Other languages
English (en)
Inventor
Braham Shroot
Shroot Braham
Jacques Eustache
Eustache Jacques
Jean-Michel Bernardon
Bernardon Jean-Michel
Original Assignee
Cird
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cird filed Critical Cird
Publication of ZA89441B publication Critical patent/ZA89441B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/92—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA89441A 1988-01-20 1989-01-19 Aromatic esters and thioesters,a process for their preparation and their use in human or veterinary medicine and in cosmetic compositions ZA89441B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU87109A LU87109A1 (fr) 1988-01-20 1988-01-20 Esters et thioesters aromatiques,leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique

Publications (1)

Publication Number Publication Date
ZA89441B true ZA89441B (en) 1989-10-25

Family

ID=19731014

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA89441A ZA89441B (en) 1988-01-20 1989-01-19 Aromatic esters and thioesters,a process for their preparation and their use in human or veterinary medicine and in cosmetic compositions

Country Status (16)

Country Link
US (1) US4925658A (de)
EP (1) EP0325540B1 (de)
JP (1) JP2753300B2 (de)
AT (1) ATE88175T1 (de)
AU (1) AU613445B2 (de)
CA (1) CA1338561C (de)
DE (1) DE68905929T2 (de)
DK (1) DK23189A (de)
ES (1) ES2054038T3 (de)
FI (1) FI93352C (de)
IE (1) IE68445B1 (de)
LU (1) LU87109A1 (de)
NO (1) NO170009C (de)
NZ (1) NZ227666A (de)
PT (1) PT89480B (de)
ZA (1) ZA89441B (de)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4448006A (en) 1981-05-28 1984-05-15 Donn Incorporated Grid ceiling structure and method of converting
FR2649977B1 (fr) * 1989-07-18 1991-10-04 Cird Esters bi-aromatiques, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
FR2728166A1 (fr) 1994-12-19 1996-06-21 Oreal Composition topique contenant un antagoniste de substance p
FR2729854A1 (fr) 1995-01-26 1996-08-02 Oreal Utilisation du sulfate de dehydroepi-androsterone dans une composition cosmetique ou dermatologique
FR2741878B1 (fr) * 1995-12-01 1998-01-09 Cird Galderma Composes biaromatiques portant un groupement adamantyl en ortho, compositions pharmaceutiques et cosmetiques les contenant et utilisations
US20050113283A1 (en) * 2002-01-18 2005-05-26 David Solow-Cordero Methods of treating conditions associated with an EDG-4 receptor
EP2377532A1 (de) 2004-08-18 2011-10-19 Ace ApS Kosmetische und pharmazeutische Zusammensetzungen mit ACE-Hemmern und/oder Angiotensin-II-Rezeptorantagonisten zur Behandlung von Hauterkrankungen
US8158136B2 (en) 2004-08-18 2012-04-17 L'oréal Emulsification system for use in cosmetics
AU2005291098B2 (en) * 2004-10-04 2011-11-24 L'oreal Cosmetic and/or dermatological composition for sensitive skins
FR2889057B1 (fr) * 2005-08-01 2008-07-18 Oreal Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches
FR2889808B1 (fr) 2005-08-17 2011-07-22 Oreal Utilisation de l'acide 8-hexadecene-1,16-dicarboxylique comme agent de soin destine a favoriser la cohesion de la couche cornee
FR2910320B1 (fr) 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
FR2910321B1 (fr) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
JP2011512164A (ja) 2007-02-20 2011-04-21 ガルデルマ・リサーチ・アンド・デヴェロップメント 皮膚内への治療物質の送達方法
FR2912651A1 (fr) 2007-02-21 2008-08-22 Oreal Emulsion e/h pour le soin de la peau.
FR2912917B1 (fr) 2007-02-26 2012-05-18 Oreal Milieu conditionne et ses utilisations
FR2918886B1 (fr) 2007-07-17 2010-01-08 Oreal Utilisation d'au moins un extrait bacterien cultive sur eau thermale pour le traitement des peaux, muqueuses et cuirs chevelus sensibles
FR2919501B1 (fr) * 2007-08-02 2010-12-31 Oreal Utilisation d'hesperidine ou de l'un de ses derives pour la prevention et/ou le traitement des peaux relachees
FR2920304B1 (fr) 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
WO2009031106A2 (en) * 2007-09-04 2009-03-12 L'oreal Use of a combination of hesperidin and of a microorganism for influencing the barrier function of the skin
FR2920305B1 (fr) * 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
FR2928542B1 (fr) 2008-03-13 2011-12-09 Oreal Procede de maquillage des levres
FR2931661B1 (fr) 2008-05-30 2010-07-30 Galderma Res & Dev Nouvelles compositions depigmentantes sous forme d'une composition anhydre sans vaseline et sans elastomere comprenant un derive phenolique solubilise et un retinoide.
FR2940907B1 (fr) 2009-01-15 2011-03-04 Oreal Composition cosmetique ou dermatologique, comprenant un retinoide, un compose non phosphate a base d'adenosine et un polymere semi-cristallin
FR2942719B1 (fr) 2009-03-04 2011-08-19 Oreal Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
WO2011010075A1 (fr) 2009-07-24 2011-01-27 L'oreal Utilisation d'un derive d'acide jasmonique en tant qu'agent apaisant
FR2953716B1 (fr) 2009-12-16 2015-03-27 Oreal Kit de formulation d'un produit cosmetique
FR2968952A1 (fr) 2010-12-17 2012-06-22 Oreal Ester d'acide amine n-acyle a titre d'agent apaisant
FR2981272A1 (fr) 2011-10-14 2013-04-19 Inneov Lab Utilisation d'une composition orale comprenant un melange d'au moins un polyphenol, de zinc, et de vitamine c.
US9949897B2 (en) 2012-04-11 2018-04-24 L'oreal Self-standing cosmetic sheet
FR2996135A1 (fr) 2012-09-28 2014-04-04 Inneov Lab Composition orale pour renforcer la tolerance cutanee suite a une administration topique d'un compose retinoide.
EP2789369B1 (de) 2013-04-14 2018-06-06 Symrise AG Eine Zubereitung zur Aufhellung von Haut und Haaren
EP2842607B1 (de) 2013-09-02 2018-05-30 Symrise AG Eine Mischung zur Aufhellung von Haut und/oder Haaren
CN105555366B (zh) 2013-09-22 2020-12-01 西姆莱斯股份公司 海马齿苋提取物及其应用
EP2853254B1 (de) 2013-09-26 2017-11-08 Symrise AG Kosmetische Zusammensetzung zur Aufhellung von Haut und/oder Haaren
EP2859883B1 (de) 2013-10-13 2019-05-15 Symrise AG Mischungen von Aktivstoffen enthaltend acylierte Oligopeptide und Troxerutin
US20160250121A1 (en) 2013-10-29 2016-09-01 Paolo Pertile Use of mono ornithine ketoglutarate (mokg)
EP3443950A1 (de) 2014-07-30 2019-02-20 Symrise AG Prafümzubereitung
EP3023090B1 (de) 2014-11-21 2019-08-07 Symrise AG Zubereitungen
EP3045161B1 (de) 2015-01-18 2026-03-25 Symrise AG Verwendung von Wirkstoffgemischen aus 1,2-Hexandiol und 1,2-Octandiol in kosmetischen, pharmazeutischen oder dermatologischen Emulsionen
EP3081207B1 (de) 2015-04-16 2022-09-21 Symrise AG Verwendung einer liposomenzusammensetzung
EP3288534B1 (de) 2015-04-28 2020-09-23 Symrise AG Zusammensetzungen mit einem valeria extrakt
EP3097905B1 (de) 2015-05-28 2020-11-04 Symrise AG Kosmetische zubereitungen
EP3108941B1 (de) 2015-06-23 2018-05-09 Symrise AG Zubereitungen enthaltend polyalkylenglykol-derivate
CN107922882A (zh) 2015-09-08 2018-04-17 西姆莱斯股份公司 香料混合物
EP3367994B1 (de) 2015-10-28 2021-05-12 Symrise AG Verfahren zur unterdrückung oder maskierung von fischgerüchen
MX379984B (es) 2015-11-15 2025-03-11 Symrise Ag Reducción de la sensación de picazón en la piel.
WO2017097434A1 (en) 2015-12-06 2017-06-15 Symrise Ag A fragrance composition
CN109862875A (zh) 2016-03-30 2019-06-07 西姆莱斯股份公司 一种活性混合物
EP4603149A3 (de) 2016-08-20 2025-12-24 Symrise AG Konservierende mischung
JP7441042B2 (ja) 2016-12-02 2024-02-29 シムライズ アーゲー 化粧品ブレンド
FR3061002B1 (fr) 2016-12-23 2019-05-24 L'oreal Composition comprenant de l’acide hydroxyethylpiperazine ethane sulfonique et au moins un alkylpolyglucoside
IT201700090929A1 (it) 2017-08-07 2019-02-07 Cutech S R L Usi cosmetici e medici di estratti del fungo Coprinus comatus per la regolazione dell’unità pilo sebacea.
DE202017007679U1 (de) 2017-08-09 2024-03-15 Symrise Ag 1,2-Alkandiole
EP3664772B1 (de) 2017-08-09 2024-03-20 Symrise AG 1,2-alkandiole und verfahren zu ihrer herstellung
US12016944B2 (en) 2018-03-08 2024-06-25 Symrise Ag Mixtures comprising a protein extract for the treatment of human skin and/or hair
CA3113475A1 (en) 2018-09-20 2020-03-26 Symrise Ag Compositions comprising odorless 1,2-pentanediol
CN113710331B (zh) 2019-03-12 2024-03-22 西姆莱斯股份公司 一种抗微生物混合物
CN115297833B (zh) 2020-03-31 2024-07-09 莱雅公司 呈凝胶形式的化妆品组合物
US20240050337A1 (en) 2020-12-09 2024-02-15 Symrise Ag A mixture comprising 1,2-alkanediols
FR3126311B1 (fr) 2021-08-27 2024-12-20 Oreal Procede cosmetique non therapeutique pour reduire les rides sur une surface de la peau, kit pour la mise en œuvre du procede, et procede d’utilisation d’un kit
US20240350394A1 (en) 2021-07-16 2024-10-24 L'oreal A non-therapeutic cosmetic method for reducing wrinkles on a skin surface
FR3131845B1 (fr) 2022-01-19 2024-11-01 Oreal Composition stable comprenant un rétinoïde
FR3131837B1 (fr) 2022-01-19 2024-10-04 Oreal Composition stable comprenant un rétinoïde et un composé acide ascorbique
KR20240099313A (ko) 2021-12-20 2024-06-28 로레알 레티노이드를 포함하는 안정한 조성물
WO2023120390A1 (en) 2021-12-20 2023-06-29 L'oreal Stable composition comprising retinoid and ascorbic acid compound
EP4580614A1 (de) 2022-08-31 2025-07-09 L'oreal Zusammensetzung zur pflege keratinischer materialien und maske damit
FR3145278B1 (fr) 2023-01-30 2026-04-10 Oreal Composition de dispersion stable comprenant un rétinoïde
WO2024135577A1 (en) 2022-12-23 2024-06-27 L'oreal Stable dispersion composition comprising retinoid
FR3148912B1 (fr) 2023-05-24 2026-02-20 Oreal Composition comprenant des polymères cationiques et anioniques

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1290848A (de) * 1968-11-11 1972-09-27
CH586728A5 (de) * 1972-12-26 1977-04-15 Ciba Geigy Ag
US4051104A (en) * 1972-12-26 1977-09-27 Ciba-Geigy Corporation Benzoyloxybenzoates and compositions stabilized therewith

Also Published As

Publication number Publication date
FI890291A0 (fi) 1989-01-19
DK23189A (da) 1989-07-21
FI93352B (fi) 1994-12-15
CA1338561C (fr) 1996-08-27
US4925658A (en) 1990-05-15
DE68905929D1 (de) 1993-05-19
NO890252D0 (no) 1989-01-19
DK23189D0 (da) 1989-01-19
FI93352C (fi) 1995-03-27
DE68905929T2 (de) 1993-07-22
AU2860889A (en) 1989-07-20
NO170009B (no) 1992-05-25
NZ227666A (en) 1991-04-26
EP0325540B1 (de) 1993-04-14
PT89480A (pt) 1989-10-04
PT89480B (pt) 1994-08-31
ATE88175T1 (de) 1993-04-15
AU613445B2 (en) 1991-08-01
JPH029841A (ja) 1990-01-12
NO170009C (no) 1992-09-02
IE68445B1 (en) 1996-06-12
IE890152L (en) 1989-07-20
EP0325540A1 (de) 1989-07-26
NO890252L (no) 1989-07-21
JP2753300B2 (ja) 1998-05-18
LU87109A1 (fr) 1989-08-30
FI890291A7 (fi) 1989-07-21
ES2054038T3 (es) 1994-08-01

Similar Documents

Publication Publication Date Title
AU2860889A (en) Aromatic esters and thioesters, a process for their preparation and their use in human or veterinary medicine and in cosmetic compositions
NZ240189A (en) Aryl substituted amides, carbamates, carbonates, ketones and esters; preparation and pharmaceutical/cosmetic compositions thereof
SE8800949D0 (sv) Aromatiska karboxylsyraderivat och anvendning av dessa som mellanprodukter for framstellning av aromatiska heterocykliska derivat med terapeutiska och kosmetiska egenskaper
IE870121L (en) "aromatic benzamido compounds, a method for their¹preparation and their use in human and veterinary medicine¹and in cosmetics"
DK162286A (da) Benzonaphthalen-derivater, fremgangsmaade til deres fremstilling og deres anvendelse til farmaceutiske og kosmetiske formaal
ZA875261B (en) Aromatic,bicyclic derivatives,process for their preparation and their medical,veterinary and cosmetic use
HUT69176A (en) Propinyl-biaromatic derivatives and pharmaceutical and cosmetical compositions containing them
AU6385986A (en) New bicyclic naphthalene derivatives, the process for the preparation of them and the use of them in human and veterinary medicine and in cosmetics
GR890300124T1 (en) Polycyclic heterocyclic derivatives, proces for their preparation and their use in human and veterinary medicines
GR3022808T3 (en) New bi-aromatic compounds derived from amides pharmaceutical compositions and cosmetic compositions containing them and their use.
DE69001515D1 (de) Urethan-derivate, ihre herstellung und verwendung als hautbefeuchtendes mittel in kosmetischen und pharmazeutischen zubereitungen zur behandlung trockener haut.
DE69015787D1 (de) Thiophenderivate, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
HUT37767A (en) Process for preparing isoxazole derivatives further pharmaceutical compositions containing such compounds as active substances
ATE110568T1 (de) Pharmazeutisches präparat zur behandlung des katarakts.
TW261605B (de)
IL88222A0 (en) Medicaments comprising 2-pyrimidinyl-1-piperazine derivatives
ZA903111B (en) 2-hydroxy-3-phenoxypropylamino compounds and pharmaceutical compositions containing them
EP0643035A4 (de) Dermatologische präparate sowie neue benzoesäure derivate.
ATE965T1 (de) Aminopropanolderivate des 2-(o-hydroxyphenyl)-pyrrols, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
DK220088A (da) Thiadiasolguanidiner, fremgangsmaade til fremstilling deraf og afrmaceutiske praeparater indeholdende disse forbindelser